Overexpression of Plcb1 has been correlated with advanced tumor stages and poorer survival outcomes in patients with breast, gastric cancers, and hepatocellular cancer, where it is thought to facilitate the migration and invasion of cancer cells. The gene discussed is PLCB1; the disease is hepatocellular carcinoma.